John E. Wilkinson

22.9k total citations · 5 hit papers
169 papers, 15.7k citations indexed

About

John E. Wilkinson is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, John E. Wilkinson has authored 169 papers receiving a total of 15.7k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 29 papers in Genetics and 25 papers in Immunology. Recurrent topics in John E. Wilkinson's work include RNA modifications and cancer (12 papers), Renal and related cancers (12 papers) and RNA Research and Splicing (11 papers). John E. Wilkinson is often cited by papers focused on RNA modifications and cancer (12 papers), Renal and related cancers (12 papers) and RNA Research and Splicing (11 papers). John E. Wilkinson collaborates with scholars based in United States, Germany and United Kingdom. John E. Wilkinson's co-authors include Jacques Ellul, Howard Falk, Richard A. Miller, Randy Strong, Nancy L. Nadon, Elizabeth Fernández, James F. Nelson, Clinton M. Astle, Martin A. Javors and Kevin Flurkey and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

John E. Wilkinson

158 papers receiving 15.2k citations

Hit Papers

Rapamycin fed late in ... 1965 2026 1985 2005 2009 2001 1965 2010 2015 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
    2009 2.8k citations Randy Strong, Z. Dave Sharp et al. profile →
  2. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse
    2001 2.0k citations John E. Wilkinson et al. profile →
  3. The Technological Society
    1965 1.1k citations John E. Wilkinson et al. profile →
  4. Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice
    2010 686 citations Richard A. Miller, Clinton M. Astle et al. The Journals of Gerontology Series A profile →
  5. Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss
    2015 468 citations John E. Wilkinson, Adrian R. Krainer et al. Genes & Development profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John E. Wilkinson United States 51 6.4k 3.8k 2.4k 2.1k 1.9k 169 15.7k
Andrew I. Su United States 51 8.7k 1.3× 1.8k 0.5× 1.7k 0.7× 611 0.3× 1.1k 0.6× 146 16.1k
Richard A. Miller United States 69 7.3k 1.1× 3.5k 0.9× 6.4k 2.6× 6.3k 3.1× 959 0.5× 378 21.4k
Peter D. Adams United States 59 9.2k 1.4× 1.4k 0.4× 2.8k 1.1× 763 0.4× 2.6k 1.4× 224 13.7k
Cam Patterson United States 83 17.5k 2.7× 2.6k 0.7× 4.8k 2.0× 908 0.4× 2.3k 1.2× 330 26.0k
Ömer Yılmaz Türkiye 51 4.5k 0.7× 1.9k 0.5× 1.2k 0.5× 329 0.2× 2.3k 1.2× 456 13.5k
Christoph Bock Austria 71 13.9k 2.2× 2.7k 0.7× 1.2k 0.5× 305 0.1× 1.4k 0.7× 205 18.9k
Patrick R. Griffin United States 75 13.1k 2.0× 2.4k 0.6× 2.3k 1.0× 130 0.1× 2.4k 1.3× 340 23.4k
Michael D. West United States 42 8.2k 1.3× 976 0.3× 6.8k 2.8× 803 0.4× 1.1k 0.6× 120 14.1k
Matteo Pellegrini United States 84 20.4k 3.2× 1.8k 0.5× 1.0k 0.4× 394 0.2× 1.1k 0.6× 414 29.2k
Daniel Cohen France 48 5.6k 0.9× 1.2k 0.3× 1.5k 0.6× 463 0.2× 331 0.2× 174 11.9k

Countries citing papers authored by John E. Wilkinson

Since Specialization
Citations

This map shows the geographic impact of John E. Wilkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Wilkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Wilkinson more than expected).

Fields of papers citing papers by John E. Wilkinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Wilkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Wilkinson. The network helps show where John E. Wilkinson may publish in the future.

Co-authorship network of co-authors of John E. Wilkinson

This figure shows the co-authorship network connecting the top 25 collaborators of John E. Wilkinson. A scholar is included among the top collaborators of John E. Wilkinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John E. Wilkinson. John E. Wilkinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maitre, Christine L. Le, Mark Dunning, & John E. Wilkinson. (2025). OPTIMISATION OF SPATIAL TRANSCRIPTOMICS FOR ADULT HUMAN FFPE OSTEOCHONDRAL AND INTERVERTEBRAL DISC TISSUE. Osteoarthritis and Cartilage. 33. S410–S410.
2.
Wan, Ledong, Kuan‐Ting Lin, Mohammad Alinoor Rahman, et al.. (2023). Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer. Cancer Discovery. 13(7). 1678–1695. 37 indexed citations
3.
Huang, Chun‐Hao, Francisco J. Sánchez‐Rivera, Margaret C. Kennedy, et al.. (2022). A preclinical platform for assessing antitumor effects and systemic toxicities of cancer drug targets. Proceedings of the National Academy of Sciences. 119(17). e2110557119–e2110557119. 8 indexed citations
4.
Kit, Wai, Juergen Scharner, Ana S.H. Costa, et al.. (2021). ASO-Based PKM Splice-Switching Therapy Inhibits Hepatocellular Carcinoma Growth. Cancer Research. 82(5). 900–915. 79 indexed citations
5.
Xue, Bin, Chen-Hua Chuang, Haydn M. Prosser, et al.. (2021). miR-200 deficiency promotes lung cancer metastasis by activating Notch signaling in cancer-associated fibroblasts. Genes & Development. 35(15-16). 1109–1122. 52 indexed citations
6.
Fisher, Matthew, Yon Hwangbo, Caizhi Wu, et al.. (2021). BRD4 Regulates Transcription Factor ΔNp63α to Drive a Cancer Stem Cell Phenotype in Squamous Cell Carcinomas. Cancer Research. 81(24). 6246–6258. 14 indexed citations
7.
Zafra, María Paz, Marie J. Parsons, Direna Alonso‐Curbelo, et al.. (2020). An In Vivo Kras Allelic Series Reveals Distinct Phenotypes of Common Oncogenic Variants. Cancer Discovery. 10(11). 1654–1671. 71 indexed citations
8.
Fein, Miriam R., Xue‐Yan He, Ana S. Almeida, et al.. (2020). Cancer cell CCR2 orchestrates suppression of the adaptive immune response. The Journal of Experimental Medicine. 217(10). 45 indexed citations
9.
Livshits, Geulah, Direna Alonso‐Curbelo, John P. Morris, et al.. (2018). Arid1a restrains Kras-dependent changes in acinar cell identity. eLife. 7. 33 indexed citations
10.
Kastenhuber, Edward R., Gadi Lalazar, Shauna L Houlihan, et al.. (2017). DNAJB1–PRKACA fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma. Proceedings of the National Academy of Sciences. 114(50). 13076–13084. 114 indexed citations
11.
Palmbos, Phillip L., Lidong Wang, Huibin Yang, et al.. (2015). ATDC/TRIM29 Drives Invasive Bladder Cancer Formation through miRNA-Mediated and Epigenetic Mechanisms. Cancer Research. 75(23). 5155–5166. 60 indexed citations
12.
Nowak, Dawid G., Hyejin Cho, Tali Herzka, et al.. (2015). MYC Drives Pten/Trp53 -Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2. Cancer Discovery. 5(6). 636–651. 64 indexed citations
13.
Cho, Hyejin, Tali Herzka, Zheng Wu, et al.. (2014). RapidCaP, a Novel GEM Model for Metastatic Prostate Cancer Analysis and Therapy, Reveals Myc as a Driver of Pten -Mutant Metastasis. Cancer Discovery. 4(3). 318–333. 68 indexed citations
14.
Wilkinson, John E., et al.. (2014). Indicações geográficas em países em desenvolvimento: potencialidades e desafios. Revista de Política Agrícola. 23(2). 103–115. 6 indexed citations
15.
Miller, Richard A., Clinton M. Astle, Joseph A. Baur, et al.. (2010). Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice. The Journals of Gerontology Series A. 66A(2). 191–201. 686 indexed citations breakdown →
16.
Wilkinson, John E.. (2001). Dalla dittatura dell'offerta alla democrazia della domanda? Alimenti transgenici, alimenti biologici e dinamiche della domanda nell'agroalimentare. 1 indexed citations
17.
Larsen, Walter G., Hideo Nakayama, Torkel Fischer, et al.. (1998). A Study of New Fragrance Mixtures. Dermatitis. 9(4). 202–206. 2 indexed citations
18.
Larsen, Walter G., Hideo Nakayama, Torkel Fischer, et al.. (1998). A Study of New Fragrance Mixtures. American Journal of Contact Dermatitis. 9(4). 202–206. 1 indexed citations
19.
Larsen, Walter G., Hideo Nakayama, Magnus Lindberg, et al.. (1996). Fragrance Contact Dermatitis: A Worldwide Multicenter Investigation (Part I). American Journal of Contact Dermatitis. 7(2). 77–83. 3 indexed citations
20.
Larsen, Walter G., Hideo Nakayama, Magnus Lindberg, et al.. (1996). Fragrance Contact Dermatitis: A Worldwide Multicenter Investigation (Part I). Dermatitis. 7(2). 77–83. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew I. Su Breakdown of academic impact, for papers by Richard A. Miller Breakdown of academic impact, for papers by Peter D. Adams Breakdown of academic impact, for papers by Cam Patterson Breakdown of academic impact, for papers by Ömer Yılmaz Breakdown of academic impact, for papers by Christoph Bock Breakdown of academic impact, for papers by Patrick R. Griffin Breakdown of academic impact, for papers by Michael D. West Breakdown of academic impact, for papers by Matteo Pellegrini Breakdown of academic impact, for papers by Daniel Cohen
Rankless by CCL
2026